KLOW — Peptide Blend
(GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg)

Skin Repair, Inflammation Modulation & Tissue-Regeneration Signaling

KLOW is a multi-peptide research blend formulated to investigate skin regeneration, inflammation modulation, and extracellular matrix (ECM) remodeling.
The blend combines GHK-Cu, BPC-157, TB-500, and KPV—four bioactive peptides widely studied for their complementary roles in cell migration, angiogenesis, immune balance, and tissue repair signaling.

Composition

• GHK-Cu (Copper Tripeptide-1)

• BPC-157 (Body Protection Compound)

• TB-500 (Thymosin Beta-4 fragment)

• KPV (Lys–Pro–Val)

Mechanistic Overview

GHK-Cu — ECM Remodeling & Skin Signaling

GHK-Cu is a naturally occurring human tripeptide involved in collagen synthesis, elastin organization, and antioxidant defense. Experimental studies show modulation of gene expression related to skin regeneration and firmness.

BPC-157 — Cytoprotection & Tissue Repair

BPC-157 is a gastric-derived peptide investigated for cytoprotective, angiogenic, and anti-inflammatory signaling. It is frequently used in research models of soft-tissue healing, endothelial integrity, and fibroblast migration.

TB-500 — Cell Migration & Angiogenesis

TB-500, a synthetic fragment of thymosin beta-4, is studied for its role in actin regulation, cell motility, and angiogenic pathways, making it a key peptide in wound-healing and tissue-regeneration models.

KPV — Anti-Inflammatory & Immune-Modulating Peptide

KPV (Lys–Pro–Val) is a tripeptide derived from α-melanocyte–stimulating hormone (α-MSH).
Research demonstrates that KPV can modulate NF-κB signaling, reduce pro-inflammatory cytokine expression, and support immune balance in epithelial and skin models—without melanocortin receptor activation.

KPV is commonly studied for:

• Inflammation downregulation

• Skin barrier support

• Redness and irritation signaling pathways

• Gut–skin immune axis research

Synergistic Research Rationale

The KLOW blend integrates four complementary biological axes:

• Structural repair & collagen remodeling → GHK-Cu

• Cytoprotection & vascular support → BPC-157

• Cell migration & angiogenesis → TB-500

• Inflammation control & immune balance → KPV

This synergy allows investigation of skin recovery, post-inflammatory repair, and tissue-regeneration signaling in complex experimental models.

Primary Experimental Applications

• Skin regeneration and dermal remodeling research

• Inflammatory skin-condition models

• Wound-healing and angiogenesis studies

• ECM turnover and collagen organization

• Barrier repair and post-inflammatory signaling

Research Use Only — Important Notice

This KLOW peptide blend is supplied exclusively for laboratory research purposes.

• Not for human or veterinary use

• Not for diagnostic, therapeutic, or cosmetic applications

• Intended only for in vitro research and/or use in appropriately controlled experimental models by qualified professionals

All descriptions above summarize findings from preclinical and mechanistic research and are provided for educational and informational purposes only.

References

1. Pickart L., Margolina A.
   Regenerative and protective actions of the GHK-Cu peptide in the skin.
   International Journal of Molecular Sciences, 2018;19(7):1987.
   https://www.mdpi.com/1422-0067/19/7/1987

2. Sikiric P. et al.
   Stable gastric pentadecapeptide BPC-157 and tissue repair mechanisms.
   Current Pharmaceutical Design, 2011;17(16):1612–1632.
   https://pubmed.ncbi.nlm.nih.gov/21524264/

3. Goldstein A.L., Kleinman H.K.
   Thymosin beta-4: actin-sequestering peptide with roles in wound healing and angiogenesis.
   Trends in Molecular Medicine, 2003;9(12):512–518.
   https://pubmed.ncbi.nlm.nih.gov/14604823/

4. Malinda K.M. et al.
   Thymosin beta-4 accelerates wound healing and promotes angiogenesis.
   FASEB Journal, 1999;13(6):755–765.
   https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.13.6.755

5. Catania A. et al.
   The neuropeptide α-MSH in host defense.
   Scientific World Journal, 2010;10:1841–1856.
   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774629/

6. Kannengiesser K. et al.
   Anti-inflammatory properties of the α-MSH-derived tripeptide KPV.
   Journal of Investigative Dermatology, 2008;128(9):2211–2218.
   https://pubmed.ncbi.nlm.nih.gov/18432278/